Post-earnings recap
Reported
Wed, Feb 6, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Phibro Animal Health's earnings report showed an EPS of $0.41, but no revenue figures were disclosed. The stock reacted positively, increasing by 2.91%, likely due to the earnings figure meeting expectations, even without a consensus available. Investors may be encouraged by the company's focus on long-term growth despite the lack of specific guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.41 | N/A | N/A |
Management emphasized their commitment to long-term growth without offering specific guidance for the upcoming quarters. They acknowledged the current market conditions but did not express any major concerns.
Management did not provide specific guidance for future quarters.
The company remains focused on its long-term growth strategy.